Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernice Wong

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Learning Disabilities|October 23, 2004
Memory for everyday information in students with learning disabilitiesJohn K McNamara, Bernice Wong
The New Zealand Medical Journal|November 3, 2016
Comparison of documentation of patient reported adverse drug reactions on both paper-based medication charts and electronic medication charts at a New Zealand hospitalWilson Shen, Bernice Wong, Jessica Yi Ping Chin, et al.
Cancer Investigation|June 27, 2015
Effect of Ang-2-VEGF-A Bispecific Antibody in Renal Cell CarcinomaHideharu Bessho, Bernice Wong, Dachuan Huang, et al.
Anticancer Research|January 1, 2015
Inhibition of placental growth factor in renal cell carcinomaHideharu Bessho, Bernice Wong, Dan Huang, et al.
Genome Biology|September 30, 2011
First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneumWillie Yu, Waraporn Chan-On, Melissa Teo, et al.
Science Translational Medicine|October 19, 2012
Methylation subtypes and large-scale epigenetic alterations in gastric cancerHermioni Zouridis, Niantao Deng, Tatiana Ivanova, et al.
Cancer Cell|October 22, 2011
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinomaAikseng Ooi, Jing-Chii Wong, David Petillo, et al.
Anticancer Research|December 6, 2015
Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2Victoria Perrier-Trudova, Bernice Wong Huimin, Sarinya Kongpetch, et al.
Nature|September 9, 2010
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaGideon Bollag, Peter Hirth, James Tsai, et al.
The New England Journal of Medicine|January 20, 2012
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitorsFei Su, Amaya Viros, Carla Milagre, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Learning Disabilities|October 23, 2004
Memory for everyday information in students with learning disabilitiesJohn K McNamara, Bernice Wong
The New Zealand Medical Journal|November 3, 2016
Comparison of documentation of patient reported adverse drug reactions on both paper-based medication charts and electronic medication charts at a New Zealand hospitalWilson Shen, Bernice Wong, Jessica Yi Ping Chin, et al.
Cancer Investigation|June 27, 2015
Effect of Ang-2-VEGF-A Bispecific Antibody in Renal Cell CarcinomaHideharu Bessho, Bernice Wong, Dachuan Huang, et al.
Anticancer Research|January 1, 2015
Inhibition of placental growth factor in renal cell carcinomaHideharu Bessho, Bernice Wong, Dan Huang, et al.
Genome Biology|September 30, 2011
First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneumWillie Yu, Waraporn Chan-On, Melissa Teo, et al.
Science Translational Medicine|October 19, 2012
Methylation subtypes and large-scale epigenetic alterations in gastric cancerHermioni Zouridis, Niantao Deng, Tatiana Ivanova, et al.
Cancer Cell|October 22, 2011
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinomaAikseng Ooi, Jing-Chii Wong, David Petillo, et al.
Anticancer Research|December 6, 2015
Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2Victoria Perrier-Trudova, Bernice Wong Huimin, Sarinya Kongpetch, et al.
Nature|September 9, 2010
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaGideon Bollag, Peter Hirth, James Tsai, et al.
The New England Journal of Medicine|January 20, 2012
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitorsFei Su, Amaya Viros, Carla Milagre, et al.
Pageof 2